RayKnowChina Research Map
Shortlist0

Blood disorders

Aplastic anaemia

再生障碍性贫血

A form of anaemia in which the bone marrow does not make enough blood cells.

Definition adapted from MeSH (US National Library of Medicine)

hospitals in mainland China
63

with a paper from 2016–2025 or a registered study

cities
31

where those hospitals are

open trials in China
23

ClinicalTrials.gov, 8 Nov 2026

Mainland China accounts for 32% of the world's English-language research papers on aplastic anaemia, 2021–2025 (21% in 2016–2020), and 19% of the world's registered trials on it have a site in China.

Research activity in public records, not a rating of care and not medical advice. How the numbers are made

63 hospitals in 31 cities

Order: papers led on aplastic anaemia, 2021–2025, then A–Z. Research activity, not a rating of care.

A hospital is listed when it led at least 2 papers or 1 trial on aplastic anaemia, or was a site in 2 or more trials. “Papers led” counts English-language PubMed papers whose first or last author lists the hospital first. Hospitals not listed may also treat it. Definitions

A square is a city. Its size and number are hospitals listed for this disease, not the amount of research. Choose one to show that city in the hospital list and the trial list.

Cities with the most listed hospitals

  1. Beijing6
  2. Jinan6
  3. Hangzhou5
  4. Chongqing4
  5. Wuhan4
  6. Shanghai3
  7. Suzhou3
  8. Changsha2
  9. Chengdu2
  10. Fuzhou2

Each opens aplastic anaemia in that city. 21 more cities are in the menu below.

  1. Institute of Hematology & Blood Diseases Hospital, CAMS & PUMC

    中国医学科学院血液病医院(血液学研究所)Tianjin

    48 papers led
  2. 29 papers led
  3. First Affiliated Hospital of Zhejiang Chinese Medical University

    浙江中医药大学附属第一医院(浙江省中医院)Hangzhou

    24 papers led
  4. 23 papers led
    No open trial led
  5. 16 papers led
  6. 13 papers led
    No open trial led
  7. 11 papers led
  8. 9 papers led
    No open trial led
  9. 9 papers led
    No open trial led
  10. Jiangsu Province Hospital

    江苏省人民医院(南医大一附院)Nanjing

    9 papers led
    No open trial led
  11. Tongji Hospital

    华中科技大学同济医学院附属同济医院WuhanInternational Medical Department

    8 papers led
    No open trial led
  12. 7 papers led
    No open trial led
  13. Second Xiangya Hospital

    中南大学湘雅二医院Changsha

    6 papers led
    No open trial led
  14. 5 papers led
    No open trial led
  15. 5 papers led
    No open trial led
  16. Shanghai Children's Medical Center

    上海交通大学医学院附属上海儿童医学中心Shanghai

    5 papers led
    No open trial led
  17. 4 papers led
    No open trial led
  18. Henan Cancer Hospital

    河南省肿瘤医院Zhengzhou

    4 papers led
    No open trial led
  19. 4 papers led
    No open trial led
  20. 4 papers led
    No open trial led
  21. Children's Hospital, Shandong University

    山东大学附属儿童医院Jinan

    3 papers led
    No open trial led
  22. 3 papers led
    No open trial led
  23. 3 papers led
    No open trial led
  24. West China Second University Hospital

    四川大学华西第二医院Chengdu

    3 papers led
    No open trial led
  25. Xiangya Hospital

    中南大学湘雅医院Changsha

    3 papers led
    No open trial led
  26. 2 papers led
    No open trial led
  27. 2 papers led
    No open trial led
  28. 2 papers led
    No open trial led
  29. Binzhou Medical University Hospital

    山东医药大学附属医院Binzhou

    2 papers led
    No open trial led
  30. 2 papers led
    No open trial led
  31. First Affiliated Hospital of USTC

    中国科学技术大学附属第一医院(安徽省立医院)Hefei

    2 papers led
  32. 2 papers led
    No open trial led
  33. 2 papers led
    No open trial led
  34. Fujian Medical University Union Hospital

    福建医科大学附属协和医院Fuzhou

    2 papers led
    No open trial led
  35. 2 papers led
    No open trial led
  36. Hainan General Hospital / Hainan Medical University hospitals

    海南医学院附属医院/海南省人民医院Haikou

    2 papers led
    No open trial led
  37. Hebei Yanda Lu Daopei Hospital

    河北燕达陆道培医院Langfang

    2 papers led
    No open trial led
  38. 2 papers led
    No open trial led
  39. Second Hospital of Dalian Medical University

    大连医科大学附属第二医院Dalian

    2 papers led
    No open trial led
  40. 2 papers led
    No open trial led
  41. Southwest Hospital, Army Medical University

    陆军军医大学第一附属医院(西南医院)Chongqing

    2 papers led
    No open trial led
  42. 2 papers led
    No open trial led
  43. Union Hospital

    华中科技大学同济医学院附属协和医院Wuhan

    2 papers led
  44. 2 papers led
    No open trial led
  45. 2 papers led
    No open trial led
  46. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    1 paper led
  47. 1 paper led
    No open trial led
  48. 1 paper led
    No open trial led
  49. First Affiliated Hospital, Zhejiang University

    浙江大学医学院附属第一医院Hangzhou

    1 paper led
  50. Soochow Hopes Hematonosis Hospital

    苏州弘慈血液病医院Suzhou

    1 paper led
    No open trial led
  51. 1 paper led
    No open trial led
  52. 0 papers led
  53. 0 papers led
    No open trial led
  54. 0 papers led
    No open trial led
  55. Guangzhou General Hospital

    中国人民解放军南部战区总医院Guangzhou

    0 papers led
    No open trial led
  56. Jinan Military General Hospital

    中国人民解放军济南军区总医院Jinan

    0 papers led
    No open trial led
  57. PUMC Hospital

    中国医学科学院北京协和医院Beijing

    0 papers led
    No open trial led
  58. 0 papers led
    No open trial led
  59. Shanghai General Hospital

    上海市第一人民医院Shanghai

    0 papers led
    No open trial led
  60. Shanxi Bethune Hospital

    山西白求恩医院Taiyuan

    0 papers led
  61. Tongji Hospital

    同济大学附属同济医院Shanghai

    0 papers led
    No open trial led
  62. 0 papers led
    No open trial led
  63. 0 papers led
    No open trial led

By university or health system 36

Hospitals carrying a university’s name, added together, plus papers that name only the university. Same order as above.

  1. Peking Union Medical College / Chinese Academy of Medical Sciences

    北京协和医学院/中国医学科学院Beijing

    71 papers led
    3 hospitals
  2. Peking University Health Science Center

    北京大学医学部Beijing

    30 papers led
    2 hospitals
  3. Tianjin Medical University

    天津医科大学Tianjin

    23 papers led
    1 hospital
  4. Shandong University

    山东大学Jinan

    15 papers led
    6 hospitals
  5. Soochow University

    苏州大学Suzhou

    15 papers led
    2 hospitals
  6. Zhengzhou University

    郑州大学Zhengzhou

    14 papers led
    3 hospitals
  7. Capital Medical University

    首都医科大学Beijing

    12 papers led
    3 hospitals
  8. Nanjing Medical University

    南京医科大学Nanjing

    11 papers led
    3 hospitals
  9. Huazhong Univ. of Sci. & Tech. – Tongji Medical College

    华中科技大学同济医学院Wuhan

    10 papers led
    2 hospitals
  10. Central South University (Xiangya)

    中南大学湘雅Changsha

    9 papers led
    2 hospitals
  11. Qingdao University

    青岛大学Qingdao

    8 papers led
    2 hospitals
  12. Sichuan University (West China)

    四川大学华西Chengdu

    7 papers led
    2 hospitals
  13. Shandong First Medical University

    山东第一医科大学Jinan

    6 papers led
    3 hospitals
  14. Shanghai Jiao Tong University School of Medicine

    上海交通大学医学院Shanghai

    6 papers led
    2 hospitals
  15. Xuzhou Medical University

    徐州医科大学Xuzhou

    6 papers led
    2 hospitals
  16. Zhejiang University School of Medicine

    浙江大学医学院Hangzhou

    6 papers led
    5 hospitals
  17. Anhui Medical University

    安徽医科大学Hefei

    4 papers led
    1 hospital
  18. Fujian Medical University

    福建医科大学Fuzhou

    4 papers led
    1 hospital
  19. Jinan University

    暨南大学Guangzhou

    4 papers led
    1 hospital
  20. Army Medical University

    陆军军医大学Chongqing

    3 papers led
    2 hospitals
  21. Chongqing Medical University

    重庆医科大学Chongqing

    3 papers led
    2 hospitals
  22. Fudan University

    复旦大学Shanghai

    3 papers led
    3 hospitals
  23. Sun Yat-sen University

    中山大学Guangzhou

    3 papers led
    3 hospitals
  24. Wuhan University

    武汉大学Wuhan

    3 papers led
    2 hospitals
  25. Jilin University

    吉林大学Changchun

    2 papers led
    1 hospital
  26. Nantong University

    南通大学Nantong

    2 papers led
    1 hospital
  27. Southern Medical University

    南方医科大学Guangzhou

    2 papers led
    2 hospitals
  28. Southwest Medical University

    西南医科大学Luzhou

    2 papers led
    1 hospital
  29. University of Chinese Academy of Sciences

    中国科学院大学Beijing

    2 papers led
    1 hospital
  30. 2 papers led
    1 hospital
  31. Xinjiang Medical University

    新疆医科大学Urumqi

    2 papers led
    1 hospital
  32. China Medical University (Shenyang)

    中国医科大学Shenyang

    1 paper led
    1 hospital
  33. Chinese PLA General Hospital

    中国人民解放军总医院Beijing

    1 paper led
    1 hospital
  34. Tongji University

    同济大学Shanghai

    1 paper led
    1 hospital
  35. Xi'an Jiaotong University

    西安交通大学Xi'an

    1 paper led
    1 hospital
  36. Hebei Medical University

    河北医科大学Shijiazhuang

    0 papers led
    0 hospitals

23

open trials on aplastic anaemia in China

Recruiting, not yet recruiting, or by invitation, as registered on ClinicalTrials.gov on 8 Nov 2026, with at least one listed hospital as lead sponsor or site. 22 of them are led by a listed hospital. Check the registry for the current status. Whether someone can take part is decided by the study team.

Trials registered only in China’s own registry (ChiCTR) are not included. Questions to check before asking about a trial

What the phases mean (US National Cancer Institute)

  1. Recruiting
    Romiplostim Versus rhTPO for Platelet Engraftment After Transplant in MDS and AA
    Phase
    Phase 2
    Started
    2026-01
    Registry
    NCT07400341

    Age 18 years to 65 years (registered criteria)

    Led by First Affiliated Hospital of Soochow UniversitySuzhou

  2. Recruiting
    Adverse Effects of ATG/ALG Therapy in Aplastic Anemia
    Phase
    Not given
    Started
    2026-02
    Registry
    NCT07461116

    Age not stated (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  3. Recruiting
    A Novel Conditioning Regimen for Haplo-HSCT in Older Patients With SAA
    Phase
    Not given
    Started
    2026-06
    Registry
    NCT07586735

    Age 40 years to 60 years (registered criteria)

    Led by Peking University People's HospitalBeijing

  4. Recruiting
    Peripheral Blood Versus Bone Marrow Plus Peripheral Blood Grafts for Haploidentical Transplantation in Severe Aplastic Anemia
    Phase
    N/A
    Started
    2026-06
    Registry
    NCT07629947

    Age 18 years to 40 years (registered criteria)

    Led by Peking University People's HospitalBeijing

  5. Recruiting
    Phase I/II Study of Anti-CD38 Monoclonal Antibody in Refractory Severe Aplastic Anemia
    Phase
    Phase 1/Phase 2
    Started
    2026-06
    Registry
    NCT07714512

    Age 18 years to Not stated (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  6. Recruiting
    Efficacy and Safety of Sirolimus With or Without Cyclosporin A in Chinese Patients With Aplastic Anemia Refractory/Intolerant to Cyclosporin A
    Phase
    Phase 2
    Started
    2025-01
    Registry
    NCT06802055

    Age 18 years to Not stated (registered criteria)

    Led by Peking Union Medical College HospitalBeijing

  7. Recruiting
    Reproductive and Mental Health of Patients With Aplastic Anemia
    Phase
    Not given
    Started
    2025-03
    Registry
    NCT06936930

    Age 18 years to 40 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  8. Recruiting
    Dose-attenuated IST and Hetrombopag in Elderly (≥65 Years) Patients With Severe Aplastic Anemia
    Phase
    Phase 2
    Started
    2025-02
    Registry
    NCT07010237

    Age 65 years to Not stated (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  9. Recruiting
    A Prediction Model in Pregnant Women With Aplastic Anemia
    Phase
    Not given
    Started
    2025-11
    Registry
    NCT07101770

    Age 20 years to 50 years; women only (registered criteria)

    Led by Peking University People's HospitalBeijing

  10. Recruiting
    The Safety and Efficacy of Daratumumab in Patients With Refractory Aplastic Anemia
    Phase
    Phase 1/Phase 2
    Started
    2025-12
    Registry
    NCT07287228

    Age 18 years to Not stated (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  11. Recruiting
    A Multicenter, Randomized, Open-Label Study of Haplo-Cord HSCT for the Treatment of Aplastic Anemia
    Phase
    N/A
    Started
    2025-10
    Registry
    NCT07499284

    Age 14 years to Not stated (registered criteria)

    Led by First Affiliated Hospital of Soochow University; 2 listed hospitals as study sitesHangzhou, Suzhou, Xuzhou

  12. Recruiting
    Brain Cognitive Network Abnormalities in Anemia Patients Using fNIRS
    Phase
    Not given
    Started
    2025-10
    Registry
    NCT07578675

    Age 18 years to 65 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  13. Recruiting
    CD7 CAR-T Bridging to alloHSCT for Severe Aplastic Anemia
    Phase
    Early phase 1
    Started
    2024-10
    Registry
    NCT06633328

    Age not stated (registered criteria)

    Led by First Affiliated Hospital, Zhejiang UniversityHangzhou

  14. Recruiting
    Umbilical Cord Blood-Supported Haplo-HSCT for Aplastic Anemia Treatment Study
    Phase
    N/A
    Started
    2024-06
    Registry
    NCT06650553

    Age 6 years to 75 years (registered criteria)

    Led by Shanxi Bethune HospitalTaiyuan

  15. Recruiting
    Rituximab for Serious Aplastic Anemia With Platelet Transfusion Refractoriness
    Phase
    Phase 2
    Started
    2023-02
    Registry
    NCT06254560

    Age 18 years to 70 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  16. Recruiting
    High-Altitude Hematology Observation-Stem Cell Transplantation (HALO-SCT)
    Phase
    Not given
    Started
    2023-09
    Registry
    NCT07205523

    Age not stated (registered criteria)

    Led by Affiliated Hospital of Qinghai UniversityXining

  17. Recruiting
    National Longitudinal Cohort of Hematological Diseases
    Phase
    Not given
    Started
    2020-12
    Registry
    NCT04645199

    Age not stated (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  18. Not yet recruiting
    Conditioning Regimen Containing Low-Dose ATG for the Treatment of AA Receiving sUCBT
    Phase
    Phase 2
    Started
    2027-08
    Registry
    NCT07885982

    Age 1 year to 50 years (registered criteria)

    Led by First Affiliated Hospital of USTCHefei

  19. Not yet recruiting
    Clinical Study on the Preservation of Ovarian Function in Patients With Aplastic Anemia Following Allogeneic Hematopoietic Stem Cell Transplantation Using Goserelin
    Phase
    N/A
    Started
    2026-05
    Registry
    NCT07552506

    Age 14 years to 50 years; women only (registered criteria)

    Led by Union Hospital; 3 listed hospitals as study sitesHangzhou, Wuhan, Zhengzhou

  20. Not yet recruiting
    Study of CM313(SC) Injection in Subjects With Relapsed/Refractory Aplastic Anemia
    Phase
    Phase 1/Phase 2
    Started
    2025-03
    Registry
    NCT06791824

    Age 18 years to Not stated (registered criteria)

    Lead sponsor is not a listed hospital; 1 listed hospital as study siteTianjin

  21. Not yet recruiting
    Treatment of Transfusion-dependent Nonsevere Aplastic Anemia With Luspatercept: a Multicenter Prospective Clinical Study
    Phase
    N/A
    Started
    2025-05
    Registry
    NCT06964971

    Age 18 years to 80 years (registered criteria)

    Led by First Affiliated Hospital of Zhejiang Chinese Medical UniversityHangzhou

  22. Not yet recruiting
    Efficacy and Safety of UCBT With TMI -Based Conditioning Regimen for Adults With Refractory/Relapsed Aplastic Anemia
    Phase
    Phase 2
    Started
    2025-07
    Registry
    NCT07078721

    Age 18 years to 50 years (registered criteria)

    Led by Institute of Hematology & Blood Diseases Hospital, CAMS & PUMCTianjin

  23. Enrolling by invitation
    Phase I Clinical Study of Haplo-HSCT Combined With Hypoxic 3D-Cultured Umbilical Cord MSC for the Treatment of SAA
    Phase
    Phase 1/Phase 2
    Started
    2022-08
    Registry
    NCT07299123

    Age 6 years to 60 years (registered criteria)

    Led by Chinese PLA General HospitalBeijing

Open in the full trial list

Order: recruiting first, then not yet recruiting and by invitation; newest start first. Not a ranking.

Before contacting a hospital

The same for every disease, so it is kept on one page. Each hospital page also has an enquiry letter in English and Chinese, and a name card to show staff.

Where these numbers come from

Papers

412 English-language PubMed papers on aplastic anaemia with an author in mainland China, 2021–2025; a hospital led a paper when its first or last author lists it first. Run the PubMed search

Trials

ClinicalTrials.gov records with a listed hospital as lead sponsor or site, as of 8 Nov 2026. ChiCTR is not included. Search ClinicalTrials.gov

Locations

Locations are shown at city centres. Check the hospital’s website for its address.

Suggest a correctionDownload the data (CSV)Definitions